My HPRA: Register

Search for a Veterinary Medicine

For centrally authorised product information click here

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie

  • Veterinary Medicines
 
Advanced Search
 

Download

Latest list of Authorised or Transfer Pending Products
PDF VersionXML Version

Showing 21-40 of 1849 matching medicines
Product listings were last updated on 19/09/2019
Trade Name Licence Number & Holder Documents
Advantage 40 mg Spot-on solution for Small Cats and Small Pet Rabbits
40 mg/pipette Spot-on solution

Compare 		VPA10021/064/001
Authorised: 24/02/2012
Bayer Limited 		SPC
Advantage 40 Spot-on solution for Cats
40 mg/pipette Spot-on solution

Compare 		VPA10021/040/001
Authorised: 23/02/2001
Bayer Limited 		SPC
Advantage 40 Spot-on solution for Dogs
40 mg/pipette Spot-on solution

Compare 		VPA10021/041/001
Authorised: 23/02/2001
Bayer Limited 		SPC
Advantage 400 Spot-on solution for Dogs
400 mg/pipette Spot-on solution

Compare 		VPA10021/042/001
Authorised: 23/02/2001
Bayer Limited 		SPC
Advantage 80 mg Spot-on solution for Large Cats and Large Pet Rabbits
80 mg/pipette Spot-on solution

Compare 		VPA10021/064/002
Authorised: 24/02/2012
Bayer Limited 		SPC
Advantage 80 Spot-on solution for Cats
80 mg/pipette Spot-on solution

Compare 		VPA10021/040/002
Authorised: 23/02/2001
Bayer Limited 		SPC
Advantix Spot-on solution for dogs over 10 kg up to 25 kg
250.0/1250.0 mg/pipette Spot-on solution

Compare 		VPA10021/047/003
Authorised: 02/04/2004
Bayer Limited 		SPC
Advantix Spot-on solution for dogs over 25 kg up to 40 kg
400.0/2000.0 mg/pipette Spot-on solution

Compare 		VPA10021/047/004
Authorised: 02/04/2004
Bayer Limited 		SPC
Advantix Spot-on solution for dogs over 4 kg up to 10 kg.
100.0/500.0 mg/pipette Spot-on solution

Compare 		VPA10021/047/002
Authorised: 02/04/2004
Bayer Limited 		SPC
Advantix Spot-on solution for dogs over 40 kg up to 60 kg
600/3000 mg/pipette Spot-on solution

Compare 		VPA10021/047/005
Authorised: 20/10/2017
Bayer Limited 		SPC
Advantix Spot-on solution for dogs up to 4 kg
40.0/200.0 mg/pipette Spot-on solution

Compare 		VPA10021/047/001
Authorised: 02/04/2004
Bayer Limited 		SPC
Agrisept MC Tabs 2.5 g effervescent tablet for teat dip/spray solution
2.5 gram/tablet Tablet

Compare 		VPA10928/001/001
Authorised: 11/08/2004
Medentech Ltd. 		SPC
Alamycin 100 mg/ml Solution for Injection
100 milligram(s)/millilitre Solution for injection

Compare 		VPA22664/015/001
Authorised: 01/10/1988
Norbrook Laboratories (Ireland) Limited 		SPC
Alamycin Aerosol 3.2 %w/v Cutaneous Spray, solution
3.2 percent weight/volume Cutaneous spray, solution

Compare 		VPA22664/014/001
Authorised: 01/10/1988
Norbrook Laboratories (Ireland) Limited 		SPC
Alamycin LA 200 mg/ml Solution for Injection
200 milligram(s)/millilitre Solution for injection

Compare 		VPA22664/016/001
Authorised: 01/10/1988
Norbrook Laboratories (Ireland) Limited 		SPC
Alamycin LA 300 mg/ml Solution for Injection
300 milligram(s)/millilitre Solution for injection

Compare 		VPA22664/039/001
Authorised: 10/02/1994
Norbrook Laboratories (Ireland) Limited 		SPC
Albencare with Selenium Oral Suspension
150 milligram(s)/millilitre Oral suspension

Compare 		VPA10915/006/001
Authorised: 10/01/1997
Ancare Ireland Ltd. 		SPC
Albex 10 % Oral Suspension
10 percent weight/volume Oral suspension

Compare 		VPA10987/142/002
Authorised: 22/04/1996
Chanelle Pharmaceuticals Manufacturing Limited 		SPC
Albex 2.5 % Oral Suspension
2.5 percent weight/volume Oral suspension

Compare 		VPA10987/142/001
Authorised: 22/04/1996
Chanelle Pharmaceuticals Manufacturing Limited 		SPC
Albiotic 330 mg/100 mg Intramammary Solution
330, 100 mg/syringe Intramammary solution

Compare 		VPA10782/028/001
Authorised: 24/03/2016
Huvepharma NV 		SPC
« First« Previous123456Next »Last »